Clinical Trials
4 trialsNCT05741164 2026-06-04
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
Emory University
Phase 2 Recruiting
NCT05429970 2026-05-18
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT06445166 2026-04-06
Propranolol for the Treatment of Kaposi Sarcoma in Adults
Washington University School of Medicine
Phase 2 Recruiting
NCT06798363 2026-03-16
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
West China Hospital
Phase 2/3 Recruiting